Sort
48,018 grants matching “immunotherapy”
Novel gene delivery to modulate the tumor microenvironment and antigen-specific antitumor immunity
$610,783Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2025 · CA
Novel gene delivery to modulate the tumor microenvironment and antigen-specific antitumor immunity
$610,783Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2024 · CA
Role of DeltaNp63 alpha and TIP60 in SCC progression and chemoresistance
$610,770Madhavi P Kadakia · Wright State University · R01 · FY2025 · CA
Correlative biomarkers of IL-6 blockade combined with checkpoint inhibition
$610,766Jeffrey S Weber · New York University School Of Medicine · R01 · FY2020 · CA
Novel Approaches to CD33-Directed Radioimmunotherapy
$610,755Roland Bruno Walter · Fred Hutchinson Cancer Center · R37 · FY2022 · CA
Regulation of anti-tumor immunity by HDAC11
$610,695Edward Seto · George Washington University · R01 · FY2020 · CA
Study of CAR T cells and mechanisms of resistance in pediatric brain tumors
$610,644Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Host Response to TB and AIDS
$610,625New York University School Of Medicine · R01 · FY2004 · HL
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$610,603Brad Kahl · University Of Wisconsin-Madison · U10 · FY2008 · CA
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment
$610,531Ruogang Zhao · State University Of New York At Buffalo · R01 · FY2023 · CA
New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B
$610,511Larisa Y Poluektova · University Of Nebraska Medical Center · R01 · FY2022 · AI
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion
$610,423Ioannis Vlachos · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Development of small molecule selective inhibitors of neuronal nitric oxide synthase (nNOS) for melanoma treatment
$610,415Sun Yang · Chapman University · R01 · FY2025 · CA
The use of chitosan for cancer vaccine delivery
$610,288John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
$610,279Katerina Abigail Politi · Yale University · R01 · FY2015 · CA
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade
$610,178Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2024 · CA
Tumor cell lineage diversity and composition in gastric cancer progression and therapy resistance
$610,140Linghua Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.
$610,097Yvonne Yu-Hsuan Chen · University Of California Los Angeles · R01 · FY2025 · NS
Brain Tumors - Immunological and Biological Studies
$609,977Duke University · R37 · FY2003 · CA
ASSESSMENT OF ENDOGENOUS AND CAR T-CELL IMMUNITY FOLLOWING ANTI-PD-1 AGENT AS A TRANSITION STEP TO PHASE 2 COMBINATION IMMUNOTHERAPY
$609,922Sloan-Kettering Institute For Cancer Research · · FY2019 · Department of the Army
Immune Impact on Cancer Chemoresistance
$609,903Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Memory, Phenotype, and Function of TB-reactive Human MR1 Restricted T cells
$609,882David M. Lewinsohn · Oregon Health & Science University · R01 · FY2020 · AI
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$609,879Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Immunotherapy Strategies for Uveal Melanoma
$609,879Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Regulating the glioma immune microenvironment
$609,700Joanna Phillips · University Of California, San Francisco · R01 · FY2025 · NS